Literature DB >> 18196974

A direct protein-protein interaction is involved in the suppression of beta-catenin transcription by retinoid X receptor alpha in colorectal cancer cells.

Anjia Han1, Chang Tong, Dong Hu, Xiuli Bi, Wancai Yang.   

Abstract

Using both mammalian two-hybrid assay in vivo and immunoprecipitation in vitro we found that retinoid X receptor alpha (RXR alpha) directly interacted with beta-catenin and suppressed beta-catenin transcription activity and protein expression in colorectal cancer cells. But, reduction of RXR alpha by small interfering RNA upregulated beta-catenin transcriptional activity and protein expression. However, gain- or loss-expression of beta-catenin did not affect RXR alpha. Therefore, our data provided the first evidence tht RXR alpha directly interacted with beta-catenin and regulated beta-catenin transcription, which provides important information for developing novel strategies in colorectal cancer prevention by targeting RXR alpha-beta-catenin signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18196974      PMCID: PMC2820390          DOI: 10.4161/cbt.7.3.5455

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  29 in total

1.  Retinol decreases beta-catenin protein levels in retinoic acid-resistant colon cancer cell lines.

Authors:  Alice C Dillard; Michelle A Lane
Journal:  Mol Carcinog       Date:  2007-04       Impact factor: 4.784

2.  Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers.

Authors:  Clinton J Grubbs; Ronald A Lubet; Venkatram R Atigadda; Konstantin Christov; Anil M Deshpande; Vivek Tirmal; Gang Xia; Kirby I Bland; Isao Eto; Wayne J Brouillette; Donald D Muccio
Journal:  Carcinogenesis       Date:  2005-12-12       Impact factor: 4.944

3.  Organ-specific expression profiles of rat mammary gland, liver, and lung tissues treated with targretin, 9-cis retinoic acid, and 4-hydroxyphenylretinamide.

Authors:  Yian Wang; Ruisheng Yao; Anna Maciag; Clinton J Grubbs; Ronald A Lubet; Ming You
Journal:  Mol Cancer Ther       Date:  2006-04       Impact factor: 6.261

4.  Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin.

Authors:  M Bordonaro; J M Mariadason; F Aslam; B G Heerdt; L H Augenlicht
Journal:  Cell Growth Differ       Date:  1999-10

5.  Repression of beta-catenin function in malignant cells by nonsteroidal antiinflammatory drugs.

Authors:  Desheng Lu; Howard B Cottam; Maripat Corr; Dennis A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-13       Impact factor: 11.205

Review 6.  Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?

Authors:  David J Mulholland; Shoukat Dedhar; Gerhard A Coetzee; Colleen C Nelson
Journal:  Endocr Rev       Date:  2005-08-26       Impact factor: 19.871

7.  JNK1 is required for sulindac-mediated inhibition of cell proliferation and induction of apoptosis in vitro and in vivo.

Authors:  Zibo Song; Chang Tong; Jiao Liang; Ashley Dockendorff; Chuanshu Huang; Leonard H Augenlicht; Wancai Yang
Journal:  Eur J Pharmacol       Date:  2007-01-19       Impact factor: 4.432

8.  Cross-regulation of beta-catenin-LEF/TCF and retinoid signaling pathways.

Authors:  V Easwaran; M Pishvaian; S Byers
Journal:  Curr Biol       Date:  1999-12-02       Impact factor: 10.834

9.  c-Jun NH2-terminal kinase 1 plays a critical role in intestinal homeostasis and tumor suppression.

Authors:  Chang Tong; Zhinan Yin; Zibo Song; Ashley Dockendorff; Chuanshu Huang; John Mariadason; Richard A Flavell; Roger J Davis; Leonard H Augenlicht; Wancai Yang
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

10.  The inhibition of Wnt/beta-catenin signalling by 1alpha,25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer cells.

Authors:  María Jesús Larriba; Noelia Valle; Héctor G Pálmer; Paloma Ordóñez-Morán; Silvia Alvarez-Díaz; Karl-Friedrich Becker; Carlos Gamallo; Antonio García de Herreros; José Manuel González-Sancho; Alberto Muñoz
Journal:  Endocr Relat Cancer       Date:  2007-03       Impact factor: 5.678

View more
  9 in total

Review 1.  Role of retinoids in the prevention and treatment of colorectal cancer.

Authors:  Catherine C Applegate; Michelle A Lane
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

2.  Effect of retinoic acid and vitamin D3 on osteoblast differentiation and activity in aging.

Authors:  Michela Bosetti; Maurizio Sabbatini; Anna Calarco; Alessia Borrone; Gianfranco Peluso; Mario Cannas
Journal:  J Bone Miner Metab       Date:  2015-02-18       Impact factor: 2.626

3.  c-Jun N-terminal kinase 1 interacts with and negatively regulates Wnt/beta-catenin signaling through GSK3beta pathway.

Authors:  Dong Hu; Wenfeng Fang; Anjia Han; Lindsay Gallagher; Roger J Davis; Bin Xiong; Wancai Yang
Journal:  Carcinogenesis       Date:  2008-10-24       Impact factor: 4.944

4.  Pleiotropic roles of the matricellular protein Sparc in tendon maturation and ageing.

Authors:  Renate Gehwolf; Andrea Wagner; Christine Lehner; Amy D Bradshaw; Cornelia Scharler; Justyna A Niestrawska; Gerhard A Holzapfel; Hans-Christian Bauer; Herbert Tempfer; Andreas Traweger
Journal:  Sci Rep       Date:  2016-09-02       Impact factor: 4.379

5.  Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells.

Authors:  H Ruan; Y Y Zhan; J Hou; B Xu; B Chen; Y Tian; D Wu; Y Zhao; Y Zhang; X Chen; P Mi; L Zhang; S Zhang; X Wang; H Cao; W Zhang; H Wang; H Li; Y Su; X K Zhang; T Hu
Journal:  Oncogene       Date:  2017-08-28       Impact factor: 9.867

6.  miR-27a-3p targeting RXRα promotes colorectal cancer progression by activating Wnt/β-catenin pathway.

Authors:  Jiangtao Liang; Jianming Tang; Huijuan Shi; Hui Li; Tiantian Zhen; Jing Duan; Lili Kang; Fenfen Zhang; Yu Dong; Anjia Han
Journal:  Oncotarget       Date:  2017-07-26

7.  The phosphorylated retinoid X receptor-α promotes diethylnitrosamine-induced hepatocarcinogenesis in mice through the activation of β-catenin signaling pathway.

Authors:  Hiroyasu Sakai; Yasuhiro Yamada; Masaya Kubota; Kenji Imai; Yohei Shirakami; Hiroyuki Tomita; Akira Hara; Masahito Shimizu
Journal:  Carcinogenesis       Date:  2022-04-25       Impact factor: 4.944

8.  GSK3beta is involved in JNK2-mediated beta-catenin inhibition.

Authors:  Dong Hu; Xiuli Bi; Wenfeng Fang; Anjia Han; Wancai Yang
Journal:  PLoS One       Date:  2009-08-13       Impact factor: 3.240

9.  Decreased RXRα is Associated with Increased β-Catenin/TCF4 in (56)Fe-Induced Intestinal Tumors.

Authors:  Shubhankar Suman; Santosh Kumar; Albert J Fornace; Kamal Datta
Journal:  Front Oncol       Date:  2015-10-08       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.